Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Stable Gastric Pentadecapeptide BPC 157 research protocol of Rat Glaucoma [PMID: 35052769] Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 research protocol of Rat Glaucoma
Heyssel, 1966
W., Ouyang, K., Anzala, O., Ogengo, J
For BPC-157 to move from experimental to evidence-based, the research community would need: Phase I (Safety) 50-100 healthy volunteers Multiple dose levels Comprehensive pharmacokinetic profiling Adverse event monitoring for 4-8 weeks minimum Phase II (Efficacy Signals) 100-300 patients with specific conditions Randomized, placebo-controlled design Validated outcome measures 3-6 month follow-up minimum Phase III (Confirmatory) 500-3000 patients Multi-site trials Long-term safety monitoring Comparison to existing treatments Currently, were stuck before Phase I even completes
US$ 25.32
US$ 23.56
US$ 23.68
US$ 23.17
